Medarex, Inc. (NASDAQ: MEDX) has announced that it will receive a milestone payment from Amgen (NASDAQ: AMGN). Unfortunately, Medarex said the amount is for an undisclosed sum for advancing an antibody into…
According to Reuters, Citigroup (C) will take $49 billion of SIVs onto its balance sheet. Reuters writes that Nissan and Chrysler may begin to partner in building new cars Reuters reports that…
We’ve had a lot of biotech stocks see their shares get the wrath of news over recent days. Now that the November-end NASDAQ Short Interest has been released, we wanted to see…
These aren’t all of the impact analyst calls, but these are the key calls that 24/7 Wall St. is focusing on: Amgen (AMGN) raised to overweight at Lehman. Encore Energy (ENP) started…
Wall St. expected Amgen (AMGN) to report a 1% decline in earnings to $1.03 a share on a 1% decline in revenue to $3.56 billion for the third quarter, according to analysts…
Douglas A. McIntyre According to Reuters, shares in Amazon (AMZN) dropped on concerns about margins in it latest earnings. Reuters writes that RIM (RIMM) will start to market its Blackberry in China. Reuters reports that…
Workers in industries that are not doing well usually get laid off. But, it is not a good omen when workers in robust sectors of the economy are losing their jobs. Countrywide…
According to Reuters, the Mortgage Bankers Association said that mortgage originations will fall next year to the lowest levels since 2000, forcing job losses for at least 30,000 more home finance professionals.…
Shares of Amgen Inc. (NASDAQ:AMGN) are under bit of pressure this morning, although not from any direct news from the company itself. Luckily for Amgen, much of the bad news may already…
Below is the short interest for selected stocks traded on the Nasdaq. The figures are as of September 28 and compare to numbers as of September 14, 2007. Largest Short Positions Company …
It seems that the thoughts of 24/7 Wall St. aren’t alone in the opinion of Amgen’s (NASDAQ:AMGN) future. In this morning’s issue of Business Week’s "Inside Wall Street" segment, George Putnam of…
Amgen Inc. (NASDAQ:AMGN) is seeing shares trade up another 2% pre-market after yesterday’s decision where an FDA panel rejected a proposal to set a specific target for red blood-cell levels in kidney-failure…
Amgen (NASDAQ:AMGN) has a huge day ahead of it. The biotech giant is presenting data today on the appropriateuse of Erythropoiesis Stimulating Agents in Chronic RenalFailure patients to a joint meeting of…
Amgen (NASDAQ:AMGN) has seen a slight recovery of late, mostly on reports that the U.S. Senate is asking Centers for Medicaid and Medicare Services to reconsider the drastically cut reimbursement rates. Shares…
According to Reuters, Dell (DELL) will restate four years of results after an audit that lasted over a year. Reuters writes that Bear Steans (BSC) will cut 240 jobs in its sub-prime…
